Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at firstname.lastname@example.org if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to email@example.com so that we can defer those challenges. Your health and safety are paramount to us.
Posted 24 May 2012
BREAKING UPDATE: In a 96-1 vote, the US Senate has passed the Food and Drug Administration Safety and Innovation Act. The bill will now wait to be merged with the House of Representatives' version of the same legislation. Politico has more on this piece of breaking news.
After multiple days of political wrangling and an unexpectedly large number of amendments, the Food and Drug Administration Safety and Innovation Act(FDASIA) is finally scheduled to be voted on during a Thursday, 24 May session of the US Senate.
The vote had originally been scheduled for Wednesday, but was repeatedly pushed back in the face of dozens of amendments being offered by various Senators-some of which were entirely unrelated to the legislation.
After Senate Majority Leader Harry Reid threatened to table the bill entirely if amendments were not withdrawn, the list of 39 proposed amendments was eventually whittled down to just 11.
Those amendments and their general topics are as follows:
The bill is set to be voted on at 2:00 pm on 24 May, with an agreement in place to suspend all debate at that time.
The Hill reports some of the more controversial provisions of the bill, including a proposal by Sen. David Vitter (R-LA) to attach a National Flood Insurance reauthorization bill and a proposal by various senators to kill an impending excise tax on medical devices, have been removed in the interest of keeping the bill as un-controversial as possible.
Senate Floor Schedule for Thursday, May 24, 2012
The Hill - Reid says Senate is waiting on Republicans on FDA amendments
Tags: Device Tax, Amendments, Reid, FDASIA, Delay, User Fee, MDUFA, Latest News, Senate, GDUFA, PDUFA